Thrombolytic Therapy: State of the Art
It is dangerous to take a position on the “state of the art” of thrombolytic therapy, particularly since a number of larger studies are being conducted and may be completed before this paper appears. The available data at the time of this meeting have convinced us that thrombolytic therapy is the preferred mode of treatment in a subgroup of patients with acute myocardial infarction: patients with extensive anterior myocardial ischemia or inferoposterior ischemia, who can be treated within 4–6 h after the onset of symptoms.
KeywordsDepression Ischemia Cardiol Plasminogen Streptokinase
Unable to display preview. Download preview PDF.
- 1.Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1: 397–402Google Scholar
- 2.Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico (GISSI) (1987) Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 2: 871–874Google Scholar
- 6.Serruys PW, Simoons ML, Suryapranata H et al. (1986) Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 729–742Google Scholar
- 8.Vermeer F, Simoons ML, Zwaan C de etal. Cost benefit analysis of early thrombolytic therapy with intracoronary streptokinase. Br Heart J (in press)Google Scholar
- 10.Topol EJ, Califf RM, George BS etal., TAMI Study Group (1987) A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317: 581–588Google Scholar